ACRS vs INTC · rev $3.6M vs rev $29.70B
Aclaris Therapeutics Inc (ACRS) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
ACRS currently screens at market cap $615.9M. INTC currently screens at market cap $498.43B.
Not investment advice. Open the ACRS and INTC stock pages for the full models.
Not investment advice.